Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VisionQuest’s EyeStar software has screened over 190,000 patients for diabetic retinopathy across Mexico. The company received FDA clearance for its Image Quality Analyzer software. Its new device for detecting diabetic peripheral neuropathy recently won a $1M NIH grant and is undergoing clinical validation. The ASPIRE system uses AI to diagnose cerebral malaria via retinal images and has been tested at clinics across Africa with plans to expand further.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VisionQuest Biomedical.